Investor Presentation First Nine Months of 2022

136 Investor presentation First nine months of 2022 GLP-1 market share and market growth in North America Operations GLP-1 market growth and Novo Nordisk market share 70% 60% 50% 40% DKK billion 80% 61% 63% 60% 150 55% 53% 40% 51% GLP-1 market size and growth NAO -53% 33 230 -1 49 -63% 55% 30% 20% Aug Aug Aug Novo Nordisk -NN market share NN share of growth 2021 2019 2022 Eli Lilly Novo Nordisk Others Aug 2022 Competitors -Market growth ―NN growth Source: IQVIA, Aug 2022, value, MAT; NN: Novo Nordisk

View entire presentation